InvestorsHub Logo
Followers 9
Posts 454
Boards Moderated 0
Alias Born 10/14/2016

Re: None

Thursday, 06/08/2017 10:07:33 AM

Thursday, June 08, 2017 10:07:33 AM

Post# of 41469
In collaboration with its auditors, Amedica continues to consider any potential impairment in relation to certain of its long-lived assets. Once this exercise is completed, the Company will promptly complete its Annual Report on Form 10-K for the fiscal year ended December 31, 2016 and file it with the SEC. Upon filing of the annual report the Company also expects to promptly file its quarterly report on Form 10-Q for the first quarter ended March 31, 2017.

All debt will retire by January 2018, or sooner. Absent new financing, Amedica expects to be compliant with its debt covenants under the Hercules loan through July 2017.

Hercules loan PREVENTS take over!

The only tiny lawsuit was settled 4Q last year.

http://www.cheneliere.info/cfiles/complementaire/complementaire_gm/fichiers/certif/8410_fvtoolkit.pdf

https://www.forbes.com/sites/allbusiness/2014/12/19/20-key-due-diligence-activities-in-a-merger-and-acquisition-transaction/#1a09c6ef4bfc (esp. # 4):

4. Strategic Fit with Buyer. The buyer is concerned not only with the likely future performance of the target company as a stand-alone business; it will also want to understand the extent to which the company will fit strategically within the larger buyer organization. Related questions and areas of inquiry will include the following:

Some fool on ST tries to spin that no BO mention in the 8K...lmao ...that would be so illegal to mention until it's, the BO is finalized!

That is why it's called Due Diligence for investors to dig in and foresee the acquisition is in the making. The company can't disclose these as of now....still lmao as someone expect to read that in the 8K this morning.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News